Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 98, Issue 5, 2003, Pages 978-984

  Treggiari, Miriam M ^a,b   Walder, Bernhard ^a   Suter, Peter M ^a   Romand, Jacques André ^a  

^a Faculty of Medicine   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cerebral aneurysm; Delayed ischemic neurologicai deficit; Intracranial vasospasm; Triple H therapy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANEURYSM SURGERY; ARTICLE; BRAIN ISCHEMIA; BRAIN VASOSPASM; CALCULATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; EMBASE; FLUID THERAPY; HEMODILUTION; HUMAN; HYPERTENSION; HYPERVOLEMIA; MAJOR CLINICAL STUDY; MEDLINE; METHODOLOGY; NEUROLOGIC DISEASE; POPULATION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 0037405130     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.5.0978     Document Type: Article

References (37)

1. Adnet P, Moinardeau V, Riegel B, et al: Remplissage vasculaire et nimodipine dans le traitement du vasospasme cerebral apres cure chirurgicale d'un anevrysme intracranien. Agressologie 31:385-388, 1990
2. Biller J, Godersky JC, Adams HP Jr: Management of aneurysmal subarachnoid hemorrhage. Stroke 19:1300-1305, 1988
3. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
4. Diringer MN, Wu KC, Verbalis JG, et al: Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage. Ann Neurol 31:543-550, 1992
5. Dorsch NW: Cerebral arterial spasm - a clinical review. Br J Neurosurg 9:403-412, 1995
6. Dorsch NW: The effect and management of delayed vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir 38:156-160, 1998
7. Feigin VL, Rinkel GJ, Algra A, et al: Circulatory volume expansion for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev:CD000483, 2000
8. Finn SS, Stephensen SA, Miller CA, et al: Observations on the perioperative management of aneurysmal subarachnoid hemorrhage. J Neurosurg 65:48-62, 1986
9. Gumprecht H, Winkler R, Gerstner W, et al: Therapeutic management of grade IV aneurysm patients. Surg Neurol 47:54-58, 1997
10. Hadeishi H, Mizuno M, Suzuki A, et al: Hyperdynamic therapy for cerebral vasospasm. Neurol Med Chir 30:317-323, 1990
11. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14-20, 1968
12. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12, 1996
13. Kosnik EJ, Hunt WE: Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 45:148-154, 1976
14. Lennihan L, Mayer SA, Fink ME, et al: Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31:383-391, 2000
15. Levy ML, Giannotta SL: Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 75:27-31, 1991
16. Levy ML, Rabb CH, Zelman V, et al: Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg 79:494-499, 1993
17. Medlock MD, Dulebohn SC, Elwood PW: Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery 30:12-16, 1992
18. Miller JA, Dacey RG Jr, Diringer MN: Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 26:2260-2266, 1995
19. Moher D, Pham B, Jones A, et al: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609-613, 1998
20. Mori K, Arai H, Nakajima K, et al: Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 26:1620-1626, 1995
21. Morris JA, Gardner MJ: Calculating confidence intervals for relative risks, odds ratios, and standardised ratios and rates, in Gardner MJ, Altman DG (eds): Statistics With Confidence: Confidence Intervals and Statistical Guideline. London: British Medical Journal, 1995, pp 50-63
22. Muizelaar JP, Becker DP: Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow. Surg Neurol 25:317-325, 1986
23. Okuchi K, Fujioka M, Fujikawa A, et al: Rapid natriuresis and preventive hypervolaemia for symptomatic vasospasm after subarachnoid haemorrhage. Acta Neurochir 138:951-957, 1996
24. Origitano TC, Wascher TM, Reichman OH, et al: Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 27:729-740, 1990
25. Pocock SJ, Elbourne DR: Randomized trials or observational tribulations? N Engl J Med 342:1907-1909, 2000
26. Pritz MB, Giannotta SL, Kindt GW, et al: Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 3:364-368, 1978
27. Regli L, Walder B: Aneurysmal subarachnoid hemorrhage trials, in Biller J, Bogousslavsky J (eds): Clinical Trials in Neurological Practice. Boston: Butterworth-Heinemann, 2001, pp 63-75
28. Rosenwasser RH, Delgado TE, Buchheit WA, et al: Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery 12:658-661, 1983
29. Rosenwasser RH, Jallo JI, Getch CC, et al: Complications of Swan-Ganz catheterization for hemodynamic monitoring in patients with subarachnoid hemorrhage. Neurosurgery 37:872-876, 1995
30. Schulz KF, Chalmers I, Hayes RJ, et al: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412, 1995
31. Shimoda M, Oda S, Tsugane R, et al: Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg 78:423-429, 1993
32. Solenski NJ, Haley EC Jr, Kassell NF, et al: Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 23:1007-1017, 1995
33. Solomon RA, Fink ME, Lennihan L: Prophylactic volume expansion therapy for the prevention of delayed cerebral ischemia after early aneurysm surgery. Results of a preliminary trial. Arch Neurol 45:325-332, 1988
34. Treggiari-Venzi MM, Suter PM, Romand JA: Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 48:249-262, 2001
35. Vermeij FH, Hasan D, Bijvoet HW, et al: Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage. Stroke 29:924-930, 1998
36. Yano K, Kuroda T, Tanabe Y, et al: Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy. Acta Neurochir 125:15-19, 1993
37. Yusuf S, Peto R, Lewis J, et al: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335-371, 1985